Filing Details

Accession Number:
0001288123-10-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-11 12:00:00
Reporting Period:
2010-03-10
Filing Date:
2010-03-11
Accepted Time:
2010-03-11 15:33:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098972 Antigenics Inc AGEN Biological Products, (No Disgnostic Substances) (2836) 061562417
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
935679 H Garo Armen 162 Fifth Avenue
Suite 900
New York NY 10010
Chairman & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-10 231,579 $0.77 1,683,483 No 4 A Direct
Common Stock Disposition 2010-03-11 87,628 $0.79 1,595,855 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,655,941 Indirect by Antigenics Holdings LLC and Armen Partners
Footnotes
  1. Represents settlement of restricted stock granted on March 10, 2010 in lieu of an annual cash bonus for 2009 performance.
  2. Represents only shares sold to cover minimum federal, state and local tax withholding requirements upon the vesting of the restricted shares granted in lieu of an annual cash bonus for 2009 performance.
  3. Dr. Armen is the General Partner of Armen Partners LP. As of the date of this report Armen Partners owns a total of 1,507,667 shares of Antigenics Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Armen Partners and disclaims beneficial ownership except to the extent of his pecuniary interest therein. Dr. Armen is also CEO, Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which, as of the date of this report, owns 11,154,274 shares of Antigenics Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims benficial ownership except to the extent of his pecuniary interest therein.